LongBio Pharma (Suzhou) Co., Ltd. (HKG:1779)
105.80
+5.10 (5.06%)
Sep 30, 2026, 4:08 PM HKT
| Market Cap | 7.85B |
| Revenue (ttm) | n/a |
| Net Income | -249.58M |
| EPS | -4.04 |
| Shares Out | 74.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 146,500 |
| Open | 100.70 |
| Previous Close | 100.70 |
| Day's Range | 100.70 - 107.30 |
| 52-Week Range | 72.65 - 165.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 20, 2026 |